Cyproheptadine Hydrochloride Tablet
Product Images NDC 52817-210

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 52817-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4mg100ct

This text provides information on a medication with NDC 52817-210-10 containing 4mg Cyproheptadine Hydrochloride USP and its storage conditions. The usual dosage can be found in the package insert or full prescribing information. The medication should be stored at 20° to 25°C (68° to 77°F) and should be kept out of the reach of children. The tablets should be dispensed in a well-closed container with a child-resistant closure. The medication is manufactured by Sandoz Inc. and distributed by TruPharma LLC.*

FDA Label Image

4mg500ct

This is a description of a medication called Hydrochloride in tablet form. The NDC number for this medication is 52817-210-50. Each tablet contains 4 mg of cyproheptadine hydrochloride USP. The usual dosage is not mentioned. The medication is manufactured by Apotex Pharma in Tampa, Florida. The medication should be stored between 20°C and 25°C and kept out of reach of children.*

FDA Label Image

Stru

Ca21Hz1NeHCI is a chemical compound with a molecular weight of 350.89. No further information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.